491 related articles for article (PubMed ID: 24115628)
1. Strict vegetarian diet improves the risk factors associated with metabolic diseases by modulating gut microbiota and reducing intestinal inflammation.
Kim MS; Hwang SS; Park EJ; Bae JW
Environ Microbiol Rep; 2013 Oct; 5(5):765-75. PubMed ID: 24115628
[TBL] [Abstract][Full Text] [Related]
2. Prebiotic effects: metabolic and health benefits.
Roberfroid M; Gibson GR; Hoyles L; McCartney AL; Rastall R; Rowland I; Wolvers D; Watzl B; Szajewska H; Stahl B; Guarner F; Respondek F; Whelan K; Coxam V; Davicco MJ; Léotoing L; Wittrant Y; Delzenne NM; Cani PD; Neyrinck AM; Meheust A
Br J Nutr; 2010 Aug; 104 Suppl 2():S1-63. PubMed ID: 20920376
[TBL] [Abstract][Full Text] [Related]
3. Microbiota and diabetes: an evolving relationship.
Tilg H; Moschen AR
Gut; 2014 Sep; 63(9):1513-21. PubMed ID: 24833634
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the intestinal microbiota of oligosaccharide fed mice exhibiting reduced resistance to Salmonella infection.
Petersen A; Bergström A; Andersen JB; Hansen M; Lahtinen SJ; Wilcks A; Licht TR
Benef Microbes; 2010 Sep; 1(3):271-81. PubMed ID: 21831764
[TBL] [Abstract][Full Text] [Related]
5. Microbiota and epigenetic regulation of inflammatory mediators in type 2 diabetes and obesity.
Remely M; Aumueller E; Jahn D; Hippe B; Brath H; Haslberger AG
Benef Microbes; 2014 Mar; 5(1):33-43. PubMed ID: 24533976
[TBL] [Abstract][Full Text] [Related]
6. Divergent metabolic outcomes arising from targeted manipulation of the gut microbiota in diet-induced obesity.
Murphy EF; Cotter PD; Hogan A; O'Sullivan O; Joyce A; Fouhy F; Clarke SF; Marques TM; O'Toole PW; Stanton C; Quigley EM; Daly C; Ross PR; O'Doherty RM; Shanahan F
Gut; 2013 Feb; 62(2):220-6. PubMed ID: 22345653
[TBL] [Abstract][Full Text] [Related]
7. Modulation of gut microbiota dysbioses in type 2 diabetic patients by macrobiotic Ma-Pi 2 diet.
Candela M; Biagi E; Soverini M; Consolandi C; Quercia S; Severgnini M; Peano C; Turroni S; Rampelli S; Pozzilli P; Pianesi M; Fallucca F; Brigidi P
Br J Nutr; 2016 Jul; 116(1):80-93. PubMed ID: 27151248
[TBL] [Abstract][Full Text] [Related]
8. Influence of diet on gut microbiota, inflammation and type 2 diabetes mellitus. First experience with macrobiotic Ma-Pi 2 diet.
Fallucca F; Porrata C; Fallucca S; Pianesi M
Diabetes Metab Res Rev; 2014 Mar; 30 Suppl 1():48-54. PubMed ID: 24532292
[TBL] [Abstract][Full Text] [Related]
9. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice.
Cani PD; Bibiloni R; Knauf C; Waget A; Neyrinck AM; Delzenne NM; Burcelin R
Diabetes; 2008 Jun; 57(6):1470-81. PubMed ID: 18305141
[TBL] [Abstract][Full Text] [Related]
10. Changes in gut microbiota due to supplemented fatty acids in diet-induced obese mice.
Mujico JR; Baccan GC; Gheorghe A; Díaz LE; Marcos A
Br J Nutr; 2013 Aug; 110(4):711-20. PubMed ID: 23302605
[TBL] [Abstract][Full Text] [Related]
11. Faecal microbiota composition in vegetarians: comparison with omnivores in a cohort of young women in southern India.
Kabeerdoss J; Devi RS; Mary RR; Ramakrishna BS
Br J Nutr; 2012 Sep; 108(6):953-7. PubMed ID: 22182464
[TBL] [Abstract][Full Text] [Related]
12. A dietary intervention with functional foods reduces metabolic endotoxaemia and attenuates biochemical abnormalities by modifying faecal microbiota in people with type 2 diabetes.
Medina-Vera I; Sanchez-Tapia M; Noriega-López L; Granados-Portillo O; Guevara-Cruz M; Flores-López A; Avila-Nava A; Fernández ML; Tovar AR; Torres N
Diabetes Metab; 2019 Apr; 45(2):122-131. PubMed ID: 30266575
[TBL] [Abstract][Full Text] [Related]
13. Exopolysaccharides produced by Bifidobacterium longum IPLA E44 and Bifidobacterium animalis subsp. lactis IPLA R1 modify the composition and metabolic activity of human faecal microbiota in pH-controlled batch cultures.
Salazar N; Ruas-Madiedo P; Kolida S; Collins M; Rastall R; Gibson G; de Los Reyes-Gavilán CG
Int J Food Microbiol; 2009 Nov; 135(3):260-7. PubMed ID: 19735956
[TBL] [Abstract][Full Text] [Related]
14. Microbial Community of Healthy Thai Vegetarians and Non-Vegetarians, Their Core Gut Microbiota, and Pathogen Risk.
Ruengsomwong S; La-Ongkham O; Jiang J; Wannissorn B; Nakayama J; Nitisinprasert S
J Microbiol Biotechnol; 2016 Oct; 26(10):1723-1735. PubMed ID: 27381339
[TBL] [Abstract][Full Text] [Related]
15. Intestinal microbiota and type 2 diabetes: from mechanism insights to therapeutic perspective.
Han JL; Lin HL
World J Gastroenterol; 2014 Dec; 20(47):17737-45. PubMed ID: 25548472
[TBL] [Abstract][Full Text] [Related]
16. Immunometabolism of obesity and diabetes: microbiota link compartmentalized immunity in the gut to metabolic tissue inflammation.
McPhee JB; Schertzer JD
Clin Sci (Lond); 2015 Dec; 129(12):1083-96. PubMed ID: 26464517
[TBL] [Abstract][Full Text] [Related]
17. Inulin and fructo-oligosaccharides have divergent effects on colitis and commensal microbiota in HLA-B27 transgenic rats.
Koleva PT; Valcheva RS; Sun X; Gänzle MG; Dieleman LA
Br J Nutr; 2012 Nov; 108(9):1633-43. PubMed ID: 22243836
[TBL] [Abstract][Full Text] [Related]
18. [The association of intestinal microbiota with obesity].
Morales P; Brignardello J; Gotteland M
Rev Med Chil; 2010 Aug; 138(8):1020-7. PubMed ID: 21140062
[TBL] [Abstract][Full Text] [Related]
19. Gut microbiota and metabolic syndrome.
Festi D; Schiumerini R; Eusebi LH; Marasco G; Taddia M; Colecchia A
World J Gastroenterol; 2014 Nov; 20(43):16079-94. PubMed ID: 25473159
[TBL] [Abstract][Full Text] [Related]
20. [Gut microbiota may have influence on glucose and lipid metabolism].
Hallundbæk Mikkelsen K; Nielsen MF; Tvede M; Hansen T; Pedersen OB; Holst JJ; Vilsbøll T; Knop FK
Ugeskr Laeger; 2013 Nov; 175(46):2785-8. PubMed ID: 24629316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
